Clipperton acted as sole financial advisor to Kinvent, the European leader in connected physiotherapy solutions, on its €16m growth financing led by Eurazeo Healthcare fund (Nov Santé), with the participation of existing minority shareholders including Unifund, Sofilaro, BADGE, and Raphaël Varane, among others.
This is the third round of fundraising and will enable the company to enter a new phase of acceleration, including market penetration in the United States in 2024 and increased effort on new R&D projects.
This is another testimony of Clipperton’s fast-growing track record in the digital health space. Notable recent transactions in the segment include advising Tilak Healthcare on its growth investment by Elaia and Cap Horn, Merieux’ on the $150m financing round of Dental Monitoring at a $1bn valuation, Inova Software on its $70m investment by Carlyle and Withings’ on its $60m round led by Gilde Healthcare, Eurazeo, and Bpifrance.
